Cardiac Safety Services Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The Cardiac Safety Services market size was estimated at USD 0.67 billion in 2023 and is projected to reach USD 1.41 billion in 2030 at a CAGR of 11.26% during the forecast period 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/cardiac-safety-services-market
Cardiac Safety Services refer to a set of specialized series and assessments conducted to evaluate and monitor the potential effects of drugs or medical treatments on the cardiovascular system. These services are primarily employed during the development and clinical trails of new medications, as well as in post-marketing surveillance to ensure the safety of patients.
Cardiac safety services may include services such as ECG (Electrocardiogram) analysis, QT/QTc Interval assessment, Thorough QT (TQT) Studies, Heart monitoring, cardiac imaging and safety pharmacology studies. Cardiac safety services are crucial in the pharmaceutical industry to ensure the safety and effective use of medication, particularly those that may have an impact on the cardiovascular system. By monitoring and evaluating cardiac parameters during drug development, researchers can identify and manage potential risks to patient’s health, ultimately leading to safer and more reliable treatments.
Key Findings
· Based on type, the market is bifurcated into Integrated Service and standalone Service. The integrated services dominated the market in this segment. Integrated services are provided as a bundle of services to pharmaceutical and biopharmaceutical companies.
· Based on service type, the market can be segmented into ECG/Holter measurement, blood pressure measurement, cardiovascular imaging, thorough QT studies, and other service types. The ECG/Holter Measurement Segment dominated the market in this segment and is expected to continue to dominate the market during the forecast period.
· Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, and other end users.
Top Companies Profiled:
Biotrial, Clario, Ncardia AG, Richmond Pharmacology, PhysioStim, Koninklijke Philips N.V.(BioTelemetry), Certara, Laboratory Corporation of America Holdings, Celerion, Medpace, Shanghai Medicilon Inc, Banook Group, SGS, Pharmaceutical Product Development, Eurofins Scientific SE, NEXEL Co., Ltd and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/cardiac-safety-services-market
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Recent Developments:
· In August 2022, FIFPRO and IDOVEN launched a strategic partnership to improve player health safeguards against cardiac arrest and other heart-related risks. The FIFPRO x IDOVEN Player Heart Monitoring Service pilot programme will provide players with a complimentary resource to perform voluntary heart monitoring.
· In May 2022, Novocardia launched an innovative heart failure program that combines individualized health coaching and remote patient monitoring to improve heart failure patients' lives and decrease the need for hospitalizations.
Reasons to Acquire
· Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
· Gain authentic and granular data access for the Cardiac Safety Services Market to understand the trends and the factors involved in changing market situations.
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Access Full Report: https://www.delvens.com/report/cardiac-safety-services-market
In addition to the market data for the Cardiac Safety Services Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Key Features of Global Market Report:
· Analyze competitive developments like expansions, deployments, new product launches, and acquisitions.
· Identify growth opportunities for stakeholders by pinpointing high-growth segments.
· Study global industries status and forecast, focusing on key regions.
· Conduct an in-depth analysis of product segments and applications, offering strategic recommendations for competitive advantage.
· Provide a comprehensive analysis of key regions, including SWOT and Porter's Five Forces analyses.
· Assist in making strategic business decisions and investment plans.
Browse More Reports from Delvens:
Assisted Living (AL) market size was estimated at USD 180.70 billion in 2023 and is projected to reach USD 305.70 billion in 2030 at a CAGR of 7.8% during the forecast period 2023-2030.
Congenital Heart Disease (CHD) market size was estimated at USD 4.47 billion in 2023 and is projected to reach USD 8.11 billion in 2030 at a CAGR of 8.87% during the forecast period 2023-2030.
Periodontal Disease Treatment market size was estimated at USD 799.17 million in 2023 and is projected to reach USD 1438.54 million in 2030 at a CAGR of 8.76% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
Comments
0 comment